Recently, their use has expanded to broader indications because of their proven benefits across various conditions, including cardiovascular disease, kidney disease, and obesity
RELATED: The expanding use of GLP-1s All the published studies on GLP-1s and NAFLD suggest that more research is needed to better understand the effects these medications have on NAFLD
Tirzepatide does not carry this same degree of heart rate elevation signal
[DOI] [PubMed] [Google Scholar] 150.Prado C.M., Landi F., Chew S.T.H., Atherton P.J., Molinger J., Ruck T., Gonzalez M.C
Rosenstock, B
Tchang thinks this is the completely wrong approach for retention and lifetime value: In weight - loss maintenance, people just dont want to feel like they are in a program or that theyre patients still, that theyre being medicalised